Review



a2br antagonist psb603  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Tocris a2br antagonist psb603
    Figure 7. Adenosine receptor antagonist inhibited prostate xenografts in mice: VCaP cells were grown subcutaneously in SCID mice. Treatment with <t>A2BR</t> antagonist PSB (A) and A3R antagonist MRS1220 (B) inhibited tumor growth compared to untreated. Values represent Geometric Average ± SD, signifi cance as indicated by * = P < 0.05 as measured by Bonferroni’s multiple comparisons test, Control vs. Treatment at each timepoint.
    A2br Antagonist Psb603, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 95 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a2br+antagonist+psb603/PSB+603/10__62347_slash_dziu5992-61-15-21
    Average 94 stars, based on 95 article reviews
    a2br antagonist psb603 - by Bioz Stars, 2026-10
    94/100 stars

    Images

    1) Product Images from "Transmembrane prostatic acid phosphatase: a therapeutic target in advanced prostate cancer"

    Article Title: Transmembrane prostatic acid phosphatase: a therapeutic target in advanced prostate cancer

    Journal: American Journal of Clinical and Experimental Urology

    doi: 10.62347/dziu5992

    Figure 7. Adenosine receptor antagonist inhibited prostate xenografts in mice: VCaP cells were grown subcutaneously in SCID mice. Treatment with A2BR antagonist PSB (A) and A3R antagonist MRS1220 (B) inhibited tumor growth compared to untreated. Values represent Geometric Average ± SD, signifi cance as indicated by * = P < 0.05 as measured by Bonferroni’s multiple comparisons test, Control vs. Treatment at each timepoint.
    Figure Legend Snippet: Figure 7. Adenosine receptor antagonist inhibited prostate xenografts in mice: VCaP cells were grown subcutaneously in SCID mice. Treatment with A2BR antagonist PSB (A) and A3R antagonist MRS1220 (B) inhibited tumor growth compared to untreated. Values represent Geometric Average ± SD, signifi cance as indicated by * = P < 0.05 as measured by Bonferroni’s multiple comparisons test, Control vs. Treatment at each timepoint.

    Techniques Used: Control

    Related Articles

    Injection:

    Article Title: Electroacupuncture inhibits visceral pain via adenosine receptors in mice with inflammatory bowel disease.
    Article Snippet: .. A1R antagonist DPCPX (No: C101-25MG, Sigma-Aldrich, China), A2aR antagonist ZM241385 (No: Z0153, Sigma, USA), A2bR antagonist PSB603 (No: 3198/10, Tocris, UK), and A3R antagonist MRS3777 (No: SC-204105, Santa Cruz, CA, USA) were intraperitoneally injected to stimulate the effect of the adenosine receptors. .. Sheep anti-A1R antibody (No: sc-7500, Santa Cruz), sheep anti-A2aR antibody (No: sc7504, Santa Cruz), sheep anti-A2bR antibody (No: sc-7507, Santa Cruz), rabbit anti-A3R antibody (No: sc-13,938, Santa Cruz), rabbit anti-IL-1β antibody (No: sc-7884, Santa Cruz), and sheep anti-SP antibody (No: sc-9758, Santa Cruz) were used in Western blotting as the primary antibodies.

    Article Title: Electroacupuncture inhibits visceral pain via adenosine receptors in mice with inflammatory bowel disease
    Article Snippet: .. A1R antagonist DPCPX (No: C101-25MG, Sigma-Aldrich, China), A2aR antagonist ZM241385 (No: Z0153, Sigma, USA), A2bR antagonist PSB603 (No: 3198/10, Tocris, UK), and A3R antagonist MRS3777 (No: SC-204105, Santa Cruz, CA, USA) were intraperitoneally injected to stimulate the effect of the adenosine receptors. .. Sheep anti-A1R antibody (No: sc-7500, Santa Cruz), sheep anti-A2aR antibody (No: sc-7504, Santa Cruz), sheep anti-A2bR antibody (No: sc-7507, Santa Cruz), rabbit anti-A3R antibody (No: sc-13,938, Santa Cruz), rabbit anti-IL-1β antibody (No: sc-7884, Santa Cruz), and sheep anti-SP antibody (No: sc-9758, Santa Cruz) were used in Western blotting as the primary antibodies.

    Article Title: Transmembrane prostatic acid phosphatase: a therapeutic target in advanced prostate cancer
    Article Snippet: .. The adenosine receptor inhibitor treatment groups were as follows: (1) Control (PBS injection), (2) the A2BR antagonist PSB603 (Cat # 3198, Tocris Biosciences) 0.05 mg/ kg and (3) the A3R antagonist MRS1220 (Cat # 1217, Tocris Biosciences) 0.05 mg/kg, all given intraperitoneally three times weekly for 4 weeks. .. VCaP cells were grown on collagen coated 35-mm glass-bottom culture dishes (MatTek #P35GCOL-1.0-14-C), fixed with 3.7% formaldehyde, permeabilized with methanol and blocked with 5% BSA in PBS.

    Article Title: Electroacupuncture inhibits visceral pain via adenosine receptors in mice with inflammatory bowel disease
    Article Snippet: .. Reagents and instruments A1R antagonist DPCPX (No: C101-25MG, Sigma-Aldrich, China), A2aR antagonist ZM241385 (No: Z0153, Sigma, USA), A2bR antagonist PSB603 (No: 3198/10, Tocris, UK), and A3R antagonist MRS3777 (No: SC-204105, Santa Cruz, CA, USA) were intraperitoneally injected to stimulate the effect of the adenosine receptors. .. Sheep anti-A1R antibody (No: sc-7500, Santa Cruz), sheep anti-A2aR antibody (No: sc-7504, Santa Cruz), sheep anti-A2bR antibody (No: sc-7507, Santa Cruz), rabbit anti-A3R antibody (No: sc-13,938, Santa Cruz), rabbit anti-IL-1β antibody (No: sc-7884, Santa Cruz), and sheep anti-SP antibody (No: sc-9758, Santa Cruz) were used in Western blotting as the primary antibodies.

    Control:

    Article Title: Transmembrane prostatic acid phosphatase: a therapeutic target in advanced prostate cancer
    Article Snippet: .. The adenosine receptor inhibitor treatment groups were as follows: (1) Control (PBS injection), (2) the A2BR antagonist PSB603 (Cat # 3198, Tocris Biosciences) 0.05 mg/ kg and (3) the A3R antagonist MRS1220 (Cat # 1217, Tocris Biosciences) 0.05 mg/kg, all given intraperitoneally three times weekly for 4 weeks. .. VCaP cells were grown on collagen coated 35-mm glass-bottom culture dishes (MatTek #P35GCOL-1.0-14-C), fixed with 3.7% formaldehyde, permeabilized with methanol and blocked with 5% BSA in PBS.



    Similar Products

    a2br antagonist psb603  (Tocris)
    94
    Tocris a2br antagonist psb603
    Figure 7. Adenosine receptor antagonist inhibited prostate xenografts in mice: VCaP cells were grown subcutaneously in SCID mice. Treatment with <t>A2BR</t> antagonist PSB (A) and A3R antagonist MRS1220 (B) inhibited tumor growth compared to untreated. Values represent Geometric Average ± SD, signifi cance as indicated by * = P < 0.05 as measured by Bonferroni’s multiple comparisons test, Control vs. Treatment at each timepoint.
    A2br Antagonist Psb603, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/a2br+antagonist+psb603/PSB+603/10__62347_slash_dziu5992-61-15-21
    Average 94 stars, based on 1 article reviews
    a2br antagonist psb603 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 7. Adenosine receptor antagonist inhibited prostate xenografts in mice: VCaP cells were grown subcutaneously in SCID mice. Treatment with A2BR antagonist PSB (A) and A3R antagonist MRS1220 (B) inhibited tumor growth compared to untreated. Values represent Geometric Average ± SD, signifi cance as indicated by * = P < 0.05 as measured by Bonferroni’s multiple comparisons test, Control vs. Treatment at each timepoint.

    Journal: American Journal of Clinical and Experimental Urology

    Article Title: Transmembrane prostatic acid phosphatase: a therapeutic target in advanced prostate cancer

    doi: 10.62347/dziu5992

    Figure Lengend Snippet: Figure 7. Adenosine receptor antagonist inhibited prostate xenografts in mice: VCaP cells were grown subcutaneously in SCID mice. Treatment with A2BR antagonist PSB (A) and A3R antagonist MRS1220 (B) inhibited tumor growth compared to untreated. Values represent Geometric Average ± SD, signifi cance as indicated by * = P < 0.05 as measured by Bonferroni’s multiple comparisons test, Control vs. Treatment at each timepoint.

    Article Snippet: The adenosine receptor inhibitor treatment groups were as follows: (1) Control (PBS injection), (2) the A2BR antagonist PSB603 (Cat # 3198, Tocris Biosciences) 0.05 mg/ kg and (3) the A3R antagonist MRS1220 (Cat # 1217, Tocris Biosciences) 0.05 mg/kg, all given intraperitoneally three times weekly for 4 weeks.

    Techniques: Control